Core Insights - The company reported a revenue of approximately RMB 7,580.7 million for the six months ending June 30, 2025, representing a 15.9% increase compared to approximately RMB 6,542.7 million for the same period in 2024 [1] - The profit attributable to ordinary shareholders for the same period was approximately RMB 1,228.1 million, an 8.0% increase from approximately RMB 1,137.2 million in 2024 [1] Financial Performance - Total assets as of June 30, 2025, were approximately RMB 85,716.6 million, a decrease of 0.4% from approximately RMB 86,032.3 million as of December 31, 2024 [1] - Equity attributable to ordinary shareholders was approximately RMB 17,703.4 million as of June 30, 2025, reflecting a 3.1% increase from approximately RMB 17,175.7 million as of December 31, 2024 [1] - Return on equity for the six months ending June 30, 2025, was 14.08% [1] - Return on total assets for the same period was 3.11% [1]
环球医疗(02666.HK)上半年营收75.81亿元 纯利同比增长8.0%至12.28亿元